512 related articles for article (PubMed ID: 14610722)
1. Borderline personality and psychotropic medication prescription in an outpatient psychiatry clinic.
Sansone RA; Rytwinski D; Gaither GA
Compr Psychiatry; 2003; 44(6):454-8. PubMed ID: 14610722
[TBL] [Abstract][Full Text] [Related]
2. Medication utilization patterns and methods of suicidality in borderline personality disorder.
Makela EH; Moeller KE; Fullen JE; Gunel E
Ann Pharmacother; 2006 Jan; 40(1):49-52. PubMed ID: 16303987
[TBL] [Abstract][Full Text] [Related]
3. Borderline personality disorder features and utilization of treatment over two years.
Bagge CL; Stepp SD; Trull TJ
J Pers Disord; 2005 Aug; 19(4):420-39. PubMed ID: 16178683
[TBL] [Abstract][Full Text] [Related]
4. [Psychopharmacotherapy in adolescents with borderline personality disorder in inpatient and outpatient psychiatric treatment].
Wöckel L; Goth K; Matic N; Zepf FD; Holtmann M; Poustka F
Z Kinder Jugendpsychiatr Psychother; 2010 Jan; 38(1):37-49. PubMed ID: 20047175
[TBL] [Abstract][Full Text] [Related]
5. Treatment histories of borderline inpatients.
Zanarini MC; Frankenburg FR; Khera GS; Bleichmar J
Compr Psychiatry; 2001; 42(2):144-50. PubMed ID: 11244151
[TBL] [Abstract][Full Text] [Related]
6. Psychopharmacological treatment of 2195 in-patients with borderline personality disorder: A comparison with other psychiatric disorders.
Bridler R; Häberle A; Müller ST; Cattapan K; Grohmann R; Toto S; Kasper S; Greil W
Eur Neuropsychopharmacol; 2015 Jun; 25(6):763-72. PubMed ID: 25907249
[TBL] [Abstract][Full Text] [Related]
7. Treatment utilization by gender in patients with borderline personality disorder.
Goodman M; Patil U; Steffel L; Avedon J; Sasso S; Triebwasser J; Stanley B
J Psychiatr Pract; 2010 May; 16(3):155-63. PubMed ID: 20485103
[TBL] [Abstract][Full Text] [Related]
8. [Psychopharmacotherapy improves psychosocial functioning in adolescents with borderline personality disorder].
Wöckel L; Goth K; Zepf FD; Matic N; Holtmann M; Herpertz-Dahlmann B; Poustka F
Prax Kinderpsychol Kinderpsychiatr; 2010; 59(4):282-301. PubMed ID: 20491428
[TBL] [Abstract][Full Text] [Related]
9. A preliminary study of the naturalistic course of non-manualized psychotherapy for outpatients with borderline personality disorder: Patient characteristics, attrition and outcome.
Nysaeter TE; Nordahl HM; Havik OE
Nord J Psychiatry; 2010 Apr; 64(2):87-93. PubMed ID: 19958254
[TBL] [Abstract][Full Text] [Related]
10. The HYPE Clinic: an early intervention service for borderline personality disorder.
Chanen AM; McCutcheon LK; Germano D; Nistico H; Jackson HJ; McGorry PD
J Psychiatr Pract; 2009 May; 15(3):163-72. PubMed ID: 19461389
[TBL] [Abstract][Full Text] [Related]
11. A naturalistic study of changes in pharmacological prescription for borderline personality disorder in clinical practice: from APA to NICE guidelines.
Pascual JC; Martín-Blanco A; Soler J; Ferrer A; Tiana T; Alvarez E; Pérez V
Int Clin Psychopharmacol; 2010 Nov; 25(6):349-55. PubMed ID: 20838221
[TBL] [Abstract][Full Text] [Related]
12. The process of managing medications in patients with borderline personality disorder.
Silk KR
J Psychiatr Pract; 2011 Sep; 17(5):311-9. PubMed ID: 21926526
[TBL] [Abstract][Full Text] [Related]
13. Outpatient psychotherapy for borderline personality disorder: randomized trial of schema-focused therapy vs transference-focused psychotherapy.
Giesen-Bloo J; van Dyck R; Spinhoven P; van Tilburg W; Dirksen C; van Asselt T; Kremers I; Nadort M; Arntz A
Arch Gen Psychiatry; 2006 Jun; 63(6):649-58. PubMed ID: 16754838
[TBL] [Abstract][Full Text] [Related]
14. [Mental health service utilization among borderline personality disorder patients inpatient].
Cailhol L; Thalamas C; Garrido C; Birmes P; Lapeyre-Mestre M
Encephale; 2015 Apr; 41(2):115-22. PubMed ID: 25526809
[TBL] [Abstract][Full Text] [Related]
15. Treatment of outpatients with borderline personality disorder.
Sweeney DR
J Clin Psychiatry; 1987 Aug; 48 Suppl():32-7. PubMed ID: 2886495
[TBL] [Abstract][Full Text] [Related]
16. Clinical trials of treatment for personality disorders.
Paris J
Psychiatr Clin North Am; 2008 Sep; 31(3):517-26, viii. PubMed ID: 18638650
[TBL] [Abstract][Full Text] [Related]
17. Beliefs about psychotropic medication and psychotherapy among primary care patients with anxiety disorders.
Wagner AW; Bystritsky A; Russo JE; Craske MG; Sherbourne CD; Stein MB; Roy-Byrne PP
Depress Anxiety; 2005; 21(3):99-105. PubMed ID: 15965996
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of borderline personality disorder: do the number of criteria met make a difference?
Asnaani A; Chelminski I; Young D; Zimmerman M
J Pers Disord; 2007 Dec; 21(6):615-25. PubMed ID: 18072863
[TBL] [Abstract][Full Text] [Related]
19. [Symptom-focussed drug therapy in borderline personality disorder].
Schmahl C; Bohus M
Fortschr Neurol Psychiatr; 2001 Jul; 69(7):310-21. PubMed ID: 11488246
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacotherapy of borderline disorders. A review of the literature].
Dulz B
Nervenarzt; 1994 Nov; 65(11):755-61. PubMed ID: 7816151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
